Mohammad Suhaan Dar
Research Subjects
Mohammad Suhaan Dar has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Niroj Kumar Sahu
NCERT
4 shared publications - Ahmaduddin Khan
Vellore Institute of Technology
1 shared publication Chandunika R. Kalaiselvan
Vellore Institute of Technology
1 shared publication- Godavarthi Swati
Center for Nanotechnology Research , Vellore Institute of Technology, VELLORE, Vellore, TAMIL NADU, 632014, INDIA
1 shared publication - Nanasaheb Devappa Thorat
Department of Physics and Bernal Institute, University of Limerick, Castletroy, Limerick V94T9PX, Ireland
1 shared publication Shalmali Sudhindra
Vellore Institute of Technology
1 shared publication
Latest Publications
- 8 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Image-Guided Dual Magnetic−Photothermal Hyperthermia Using a Multifunctional Fe 3 O 4 −PANI−GQD Biomaterial Platform
Triple-negative breast cancer (TNBC) remains a therapeutic challenge owing to the lack of molecular targets and high recurrence rates. Here, we report a multifunctional magneto-photothermal nanoplatform (FPG), engineered from a magnetic Fe3O4 core, a near infrared (NIR)-active polyaniline shell, and fluorescent graphene quantum dots for image-guided combined hyperthermia. FPG demonstrated superior colloidal stability, retained superparamagnetism, and exhibited strong NIR absorption. Upon exposure to an alternating magnetic field (AMF) and 808 nm laser irradiation, FPG consistently raised suspension temperatures within the therapeutic hyperthermia range under in vitro conditions. The nanoplatform induced concentration-dependent cytotoxicity in MDA-MB-231 cells, with significantly enhanced tumor suppression observed under combined AMF and NIR exposure compared to single modality. In vivo, image-guided combined-mode therapy resulted in significant tumor regression with minimal systemic toxicity, as evidenced by histopathology and serum biochemistry. To demonstrate translational feasibility, an integrated AMF-NIR prototype system was developed, enabling synchronized magnetic and optical heating with thermal feedback control. This work highlights how rational interface engineering of multifunctional biomaterials can be leveraged for image-guided hyperthermia and translational cancer therapy.
- 8 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Image-Guided Dual Magnetic−Photothermal Hyperthermia Using a Multifunctional Fe 3 O 4 −PANI−GQD Biomaterial Platform
Triple-negative breast cancer (TNBC) remains a therapeutic challenge owing to the lack of molecular targets and high recurrence rates. Here, we report a multifunctional magneto-photothermal nanoplatform (FPG), engineered from a magnetic Fe3O4 core, a near infrared (NIR)-active polyaniline shell, and fluorescent graphene quantum dots for image-guided combined hyperthermia. FPG demonstrated superior colloidal stability, retained superparamagnetism, and exhibited strong NIR absorption. Upon exposure to an alternating magnetic field (AMF) and 808 nm laser irradiation, FPG consistently raised suspension temperatures within the therapeutic hyperthermia range under in vitro conditions. The nanoplatform induced concentration-dependent cytotoxicity in MDA-MB-231 cells, with significantly enhanced tumor suppression observed under combined AMF and NIR exposure compared to single modality. In vivo, image-guided combined-mode therapy resulted in significant tumor regression with minimal systemic toxicity, as evidenced by histopathology and serum biochemistry. To demonstrate translational feasibility, an integrated AMF-NIR prototype system was developed, enabling synchronized magnetic and optical heating with thermal feedback control. This work highlights how rational interface engineering of multifunctional biomaterials can be leveraged for image-guided hyperthermia and translational cancer therapy.
- Open Access
- 2 January 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (2) , 3354-3367
Electrochemically Engineered GQDs for Selective Tumor Targeting and Oxidative Nanotherapy in Triple-Negative Breast Cancer
We report a rapid and sustainable electrochemical method for producing graphene quantum dots (GQDs) from defect-rich graphene sheets using vitamin C as a redox-buffered exfoliant and sodium hydroxide to control the ionic environment. The resulting GQDs (3–10 nm) exhibit excitation-dependent green fluorescence, high aqueous dispersibility (ζ = −28.3 mV), and moderate oxidation with abundant oxygen functionalities. In vitro studies reveal selective cytotoxicity against triple-negative breast cancer (TNBC) cells via intracellular ROS generation, while sparing normal fibroblasts. In vivo fluorescence imaging in 4T1 tumor-bearing BALB/c mice confirms preferential tumor accumulation, renal clearance, and systemic biocompatibility, supported by blood biochemistry and histopathology. Compared with conventional GQD synthesis, this strategy offers faster reaction time, reduced chemical hazards, and improved therapeutic relevance. Overall, our approach introduces a clinically translatable, green nanoplatform for image-guided and ROS-amplified nanotheranostics in TNBC.
- 2 January 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (2) , 3354-3367
Open AccessElectrochemically Engineered GQDs for Selective Tumor Targeting and Oxidative Nanotherapy in Triple-Negative Breast Cancer
We report a rapid and sustainable electrochemical method for producing graphene quantum dots (GQDs) from defect-rich graphene sheets using vitamin C as a redox-buffered exfoliant and sodium hydroxide to control the ionic environment. The resulting GQDs (3–10 nm) exhibit excitation-dependent green fluorescence, high aqueous dispersibility (ζ = −28.3 mV), and moderate oxidation with abundant oxygen functionalities. In vitro studies reveal selective cytotoxicity against triple-negative breast cancer (TNBC) cells via intracellular ROS generation, while sparing normal fibroblasts. In vivo fluorescence imaging in 4T1 tumor-bearing BALB/c mice confirms preferential tumor accumulation, renal clearance, and systemic biocompatibility, supported by blood biochemistry and histopathology. Compared with conventional GQD synthesis, this strategy offers faster reaction time, reduced chemical hazards, and improved therapeutic relevance. Overall, our approach introduces a clinically translatable, green nanoplatform for image-guided and ROS-amplified nanotheranostics in TNBC.
- 1 September 2023
- Published by Springer Nature
- p. 73-91
In Vitro and In Vivo Assessment of Superparamagnetic Materials
- 1 September 2023
- Published by Springer Nature
- p. 73-91
In Vitro and In Vivo Assessment of Superparamagnetic Materials
- Open Access
- 21 August 2023
- Published by AIP Publishing in APL Bioengineering
- Vol. 7 (3) , 031502
Photothermal therapy using graphene quantum dots
The rapid development of powerful anti-oncology medicines have been possible because of advances in nanomedicine. Photothermal therapy (PTT) is a type of treatment wherein nanomaterials absorb the laser energy and convert it into localized heat, thereby causing apoptosis and tumor eradication. PTT is more precise, less hazardous, and easy-to-control in comparison to other interventions such as chemotherapy, photodynamic therapy, and radiation therapy. Over the past decade, various nanomaterials for PTT applications have been reviewed; however, a comprehensive study of graphene quantum dots (GQDs) has been scantly reported. GQDs have received huge attention in healthcare technologies owing to their various excellent properties, such as high water solubility, chemical stability, good biocompatibility, and low toxicity. Motivated by the fascinating scientific discoveries and promising contributions of GQDs to the field of biomedicine, we present a comprehensive overview of recent progress in GQDs for PTT. This review summarizes the properties and synthesis strategies of GQDs including top-down and bottom-up approaches followed by their applications in PTT (alone and in combination with other treatment modalities such as chemotherapy, photodynamic therapy, immunotherapy, and radiotherapy). Furthermore, we also focus on the systematic study of in vitro and in vivo toxicities of GQDs triggered by PTT. Moreover, an overview of PTT along with the synergetic application used with GQDs for tumor eradication are discussed in detail. Finally, directions, possibilities, and limitations are described to encourage more research, which will lead to new treatments and better health care and bring people closer to the peak of human well-being.
- 21 August 2023
- Published by AIP Publishing in APL Bioengineering
- Vol. 7 (3) , 031502
Open AccessPhotothermal therapy using graphene quantum dots
The rapid development of powerful anti-oncology medicines have been possible because of advances in nanomedicine. Photothermal therapy (PTT) is a type of treatment wherein nanomaterials absorb the laser energy and convert it into localized heat, thereby causing apoptosis and tumor eradication. PTT is more precise, less hazardous, and easy-to-control in comparison to other interventions such as chemotherapy, photodynamic therapy, and radiation therapy. Over the past decade, various nanomaterials for PTT applications have been reviewed; however, a comprehensive study of graphene quantum dots (GQDs) has been scantly reported. GQDs have received huge attention in healthcare technologies owing to their various excellent properties, such as high water solubility, chemical stability, good biocompatibility, and low toxicity. Motivated by the fascinating scientific discoveries and promising contributions of GQDs to the field of biomedicine, we present a comprehensive overview of recent progress in GQDs for PTT. This review summarizes the properties and synthesis strategies of GQDs including top-down and bottom-up approaches followed by their applications in PTT (alone and in combination with other treatment modalities such as chemotherapy, photodynamic therapy, immunotherapy, and radiotherapy). Furthermore, we also focus on the systematic study of in vitro and in vivo toxicities of GQDs triggered by PTT. Moreover, an overview of PTT along with the synergetic application used with GQDs for tumor eradication are discussed in detail. Finally, directions, possibilities, and limitations are described to encourage more research, which will lead to new treatments and better health care and bring people closer to the peak of human well-being.